We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Vioxx Risk Higher in First Two Weeks, Finds Study
Vioxx Risk Higher in First Two Weeks, Finds Study
May 3, 2006
Senior citizens who were administered Merck’s arthritis medication Vioxx faced the highest risk of heart attack during their first two weeks on the drug, according to a study published in the Canadian Medical Association Journal.